Search Result for:
Ovarian Cancer
Browse:
Education by Topic
New Online Offerings
Certificate Programs
Translated Offerings
Annual Global Meeting
Sort By
Kathleen Moore details outcome measures from three major phase III trials—KEYNOTE-B96, ROSELLA, and MIRASOL—highlighting objective response rates, progression-free and overall survival, and key safety signals.
On-Demand
Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations. 
Library
Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.
On-Demand
Discover how patient-reported outcomes highlight mirvetuximab’s ability to preserve quality of life while delivering meaningful clinical benefits for women with platinum-resistant ovarian cancer.
On-Demand
Listen to a new Journal Club with lead author Dr. Angeles Alvarez Secord and moderator Dr. Robert Coleman as they discuss details on the recently published article The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial.
On-Demand
Sudha Sundar discusses symptom-triggered testing in ovarian cancer detection, which support that early diagnosis through symptom-triggered testing which could lead to improved diagnosis of early-stage high grade serous ovarian cancer and low-volume disease. 
On-Demand
Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.  
On-Demand
Led by Dr. Floor Backes and Dr. Wendel Naumann, the Advances & Updates workgroup of the IGCS Education Committee collaborates with our industry partners year-round to provide our global community with current and future therapeutics in gynecologic cancer.
On-Demand
Listen to Dr. Matthew Powell and Dr. Wendel Naumann discuss the 2024 SGO Annual Meeting on Women’s Cancer late-breaking abstract Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY.
On-Demand
The RAMP 301 trial is evaluating the novel combination of avutometinib + defactinib versus investigator’s choice of therapy in patients with recurrent low grade serous ovarian cancer.
On-Demand
This webinar included faculty discussing the practicalities of choosing available tumor and germline testing options along with treatment options. 
On-Demand
Listen to Dr. Rachel Grisham as she shares results from her IGCS 2023 late-breaking presentation from Seoul.
On-Demand
Listen to international experts as they discuss state of the art of maintenance in first and second line, criteria for choosing treatment, and unmet needs. 
On-Demand
Held on September 30, 2022 at the IGCS 2022 Annual Global Meeting in New York City, USA. 
On-Demand
Learn new options for aplatinum resistant FRα positive patient. The webinar reviewed Forward II trial data, discuss MIRV BEV trial data updates, and discuss exciting future options.
On-Demand
This webinar explored a potential new novel therapy treatment for platinum resistant ovarian cancer.
On-Demand
Recorded Live: May 4, 2022.
On-Demand
Course 1 to 20 of 24